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Roxithromycin is an established macrolide [l] that is 
currently used in a variety of clinical situations. The 
National Committee for Clinical Laboratory Standards 
(NCCLS) [2,3] has not defined testing parameters for 
this drug because it is not used in the USA. In the course 
of our in vitro studies of macrolide antibiotics, we 
gathered sufficient data to propose quality control limits 
for microdilution and disk diffusion tests of roxi- 
throniycin and this brief note summarizes those data. 
The exercises involved 10 independent laboratories, 
each performing at least 10 replicate tests on different 
days. For broth microdilution tests, one batch of 
microdilution trays was prepared with serial dilutions of 
roxithromycin prepared in five different lots of cation- 
adjusted Mueller-Hinton broth from three ddferent 
manufacturers. For testing pneumococci, the broth was 
supplemented with lysed horse blood (2--3%), and for 
the Haernoplzilus irlflitenzae control strains, the broths 
were supplemented to produce Haemophilus Test 
Medium (HTM) [4]. A control macrolide (erythro- 
mycin or clarithromycin) was serially diluted in one lot 
of broth and the tests were repeated if those MICs were 
not within accepted limits [3]. 
For disk diffusion susceptibility tests, six different 
lots of Mueller-Hinton agar from three manufacturers 
were evaluated. The agar media were supplemented 
with defibrinated sheep blood (5%) when testing 
Streptococcus pnetrmoniae, and HTM [4] supplements 
were added for testing H. irlfluenzae. When the latter 
two species were tested, agar plates were incubated in 
5-10% COz but broth media were not. Each test plate 
received two 15-pg roxithromycin disks (one from 
Sanofi Diagnostics, Paris, France, and one from Oxoid, 
Basingstoke, UK) as well as a 15-p,g erythromycin or 
clarithromycin control disk. 
Each facility performed standard disk diffusion tests 
and broth microdilution tests precisely as outlined in 
the NCCLS documents [2,3]. O n  each of 10 separate 
days, each participant inoculated one microdilution 
tray (five roxithromycin MICs) and two disk diffusion 
test plates (one common lot and one unique lot). This 
exercise generated 500 roxithromycin MICs and 400 
zone diameters for each control strain. 
The coordinating laboratory evaluated agar dilu- 
tion susceptibility tests in order to determine whether 
the same control limits are appropriate for broth dilu- 
tion and agar dilution susceptibility tests. Wheii the 
agar plates were incubated in ambient air, the two 
methods gave essentially identical results with the 
Staphylococcus aureus and Euterococcus faeculis control 
strains. However, for those species that required in- 
creased CO2 for growth, MICs of the macrolides were 
increased by approximately one log1 dilution interval. 
When an increased COz atmosphere is required for 
growth, the upper and lower MIC limits for roxi- 
thromycin should be increased by at least one doubling 
concentration. 
The distribution of 500 broth microdilution MIC 
values for each of four control strains is displayed in 
Table 1. The proposed MIC limits for such tests are 
indicated by bold numbers: they generally include one 
doubling concentration on either side of the mode. 
When testing the E. fueculis control strain, the true 
mode fell between 4.0 and 8.0 mg/L. Consequently a 
four-dilution range (2.0-16 mg/L) is proposed. 
Table 1 Distribution of 500 broth microdilution MICs reported for each of four different quality control strains” 
MICs of roxithromycin (mg/L), number of times each value was reported 
Control strain 0.03 0.06 0.12 0.25 0.5 1.0 1.0 4.0 8.0 16 32 
Streptococcus pneumoniac 
ATCC 49619 1 137 307 55 
Staphylococcus aweus 
ATCC 29213 
Entevococcus fncdis  
ATCC 19112 
Hwmophilus injuenzae 
ATCC 49247 
1 59 382 57 1 
0 271 208 21 
65 339 96 
~ ~~ 
’Numbers in bold mhcate the proposed MIC limits for routine quality control tests. 
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Table 2 Distribution of 400" zone diameters recorded for 
1 5 - ~ g  roxithromycin disk diffusion susceptibility tests. 
Number of times each 
zone measurementb was reported 
Zone Streptococcus Staphylococcus Haemophilus 
diameter pneumoniae aureus intuenzae 
Imm) ATCC 49619 ATCC 25923 ATCC 49247 
30 
29 
28 
27 
26 
25 
24 
23 
22 
21 
15 
14 
13 
12 
11 
10 
9 
8 
7 
6 
1 
10 
43 
112 
124 
73 
28 
4 
1 
7 
17 
50 
92 
118 
85 
28 
3 
1 
19 
71 
106 
76 
68 
33 
13 
1 
12 
"Only 396 determinations were recorded for Streptococcus pneumoniae 
ATCC 49619. 
bProposed control limits are indicated by bold numbers. 
The results of disk diffusion tests with three 
different control strains are summarized in Table 2 and 
the proposed control limits are designated by bold 
numbers. A 6- or 7-mm range of zone diameters 
included >95% of the data for each of the control 
strains. 
The quality control parameters defined in Tables 1 
and 2 should be useful for monitoring susceptibility 
tests performed according to NCCLS methods. Other 
well-standardized methods might provide equally 
reliable results but our proposed control limits are not 
necessarily appropriate for such procedures. 
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A 37-year-old man presented to the Accident and 
Emergency Department in July 1997 with a 2-day 
history of swelling in the left knee. He had noticed 
a graze to the same knee 1 week previously which 
occurred while he was swimming in a public swimming 
pool. He had been seen by his general practitioner, who 
prescribed flucloxacfin, which had no effect on his 
pain and swelling. The patient was a general manager 
of a company and was fit and well with an unremark- 
able medical history. 
On examination, he was alert and orientated with 
a temperature of 38.1"C. The left knee was swollen 
with erythema and no effusion. Prepatellar tenderness 
was noted. The range of movement was &om 0 to 90'. 
There was no evidence of regional lymphadenopathy. 
A full blood count showed WCC 12.1 g/L (82% 
neutrophils), Hb 15.3 g/L, ESR 47 mm fall/h and 
CRP 80 mg/L. Knee aspiration was performed and 
yielded 7 mL of straw-colored fluid. Gram's stain 
showed no pus cells or organisms and there was no 
growth after 48 h of incubation. However, a blood- 
culture set grew Gram-positive rods which were con- 
firmed as Listeria monocytogenes using the API Listeria 
Identification Test Kit (BioMerieux, Basingstoke, UK) 
together with characteristic motility at room tempera- 
ture, catalase test, and hemolysis on horse blood agar 
[l]. The isolate was serotyped with the use of antisera 
'produced in-house' and found to be serovar 1/2a. 
A 2-mL specimen of the bursa aspirate was 
centrifuged at 10 000 g for 15 min and the deposit 
revealed Gram-variable rods. An indirect immuno- 
fluorescence test was performed on the deposit using 
two anti-listeria monoclonal antibodies [2]. The Gram- 
variable rods reacted with the monoclonal antibody 
CL17 (anti-listeria serogroup 1/2) but not the mono- 
clonal antibody CL2 (anti-listeria serogroup 4). The 
remainder of the deposit plus the fluid was trans- 
